Description
NAD+ 500 mg | Pure Lab Peptides Supply
NAD+ 500 mg: research material
Buy NAD+ 500 mg from Pure Lab Peptides Supply for laboratory research. This presentation contains lyophilized powder in one boxed 3 mL vial.
Nicotinamide adenine dinucleotide, commonly called NAD+, is the oxidized form of a coenzyme involved in redox reactions and other enzyme processes. Unlike peptides, NAD+ is a nucleotide cofactor rather than an amino-acid chain. Therefore, researchers should evaluate its chemical identity, labeled quantity, and batch documentation using specifications appropriate for this compound.
Product Overview
- Product Name: NAD+ (Nicotinamide Adenine Dinucleotide)
- Labeled Quantity: 500 mg
- Presentation: One boxed 3 mL vial
- Physical Format: Lyophilized powder
- Compound Class: Nucleotide cofactor
- Sequence: Not applicable; NAD+ is a small molecule
- Product Type: Single-compound research material
- Intended Application: In-vitro assays, compound characterization, and analytical method development
- Documentation: Product specifications and available batch-specific COA information
Choose the material and presentation
The NAD+ 500 mg presentation provides a labeled material quantity for comparison with your laboratory requirements. A 1000 mg presentation is also available. However, the labeled amount alone does not establish purity, solution concentration, or suitability for a specific assay.
The exact cofactor matters, too. NAD+ refers to the oxidized form, while NADH refers to its reduced counterpart. NADP+ and NADPH are related cofactors that contain an additional phosphate group. Similarly, NAD+ precursors are distinct starting materials and should not be treated as interchangeable with NAD+ itself.
Before selecting a material, compare its chemical identity, labeled quantity, and supporting documentation with the requirements of your analytical method or experimental protocol.
NAD+ as a research cofactor
NAD+ supports several enzyme-dependent processes, including reactions involving sirtuins such as SIRT1. Consequently, researchers investigate NAD+-dependent systems better to understand enzyme activity, regulation, and molecular interactions.
Davenport and colleagues examined structural features of the human SIRT1 catalytic domain in open and closed states. Their work described a closed complex containing ADP-ribose, a product of NAD+ hydrolysis, alongside a substrate-mimicking peptide. Their biochemical experiments also identified an inhibitory role for a C-terminal regulatory segment.
These findings help explain aspects of SIRT1 structure and regulation. However, the study did not establish cellular uptake or the performance of a purchased NAD+ preparation. Those questions require separate evidence based on the specific material, experimental conditions, and research endpoint.
Product records and batch reports
Review the available COA & Documents before assessing this material for laboratory use. Match the product name, lot number, report number, labeled quantity, and chemical form against the relevant records.
For this 500 mg presentation, the supplied COA summary identifies a batch-specific third-party laboratory report. The listed report details are:
- Lot Number: 31758
- Report Number: COA261057-027
- Date Tested: August 11, 2026
- Reported Purity: 99.9%
- Labeled Content: 500 mg
The Pure Lab Peptides summary presents selected information from the source report. If any detail differs, consult the original laboratory report as the controlling record. Also, interpret each result according to the test performed: reported purity, material content, and compound identity are distinct measurements.
Additional Product Information
| Specification | Details |
|---|---|
| CAS Number | 53-84-9 |
| Labeled Quantity | 500 mg |
| Purity | ≥99% in the general product specification; the supplied batch summary reports 99.9% |
| Sequence | Not applicable; NAD+ is a small molecule |
| Molecular Formula | C21H27N7O14P2, for the stated chemical form |
| Molecular Weight | 663.43 g/mol, for the stated chemical form |
| Research Applications | Cellular metabolism research, cofactor-dependent enzyme studies, and analytical method development |
| Manufacturing Method | Confirm the applicable manufacturing method in the product documentation; peptide-specific solid-phase synthesis should not be assumed |
| Solubility | The supplied specification states solubility in water or 1% acetic acid; verify solvent compatibility and conditions in the product records |
| Stability and Storage | The supplied specification states up to 24 months at −20°C; confirm the period and conditions against the applicable stability documentation |
| Appearance | White lyophilized powder, as specified |
| Shipping Conditions | The supplied specification states ambient-temperature shipping; follow the product-specific handling instructions upon receipt |
| Manufacturing Compliance | The supplied specification states that manufacturing takes place in a facility adhering to cGMP guidelines; confirm supporting documentation |
| Safety Information | Refer to the supplied MSDS or applicable safety data sheet |
Specification note: The molecular formula and molecular weight correspond to the stated NAD+ form. If the supplied material uses a different salt or formulation, confirm the applicable chemical composition and molecular weight in the product records. Likewise, verify the storage period, solubility, manufacturing method, and compliance claims against the relevant documentation.
NAD+ 500 mg Certificate of Analysis
Independent lot testing
The supplied product information identifies batch-specific third-party laboratory documentation for NAD+ 500 mg. The Pure Lab Peptides summary lists the following report information:
| COA Field | Reported Detail |
|---|---|
| Lot Number | 31758 |
| Report Number | COA261057-027 |
| Date Tested | August 11, 2026 |
| Reported Purity | 99.9% |
| Labeled Content | 500 mg |
Use the original laboratory report to confirm the reported results and their analytical basis. A purity figure does not automatically establish every aspect of identity, total content, stability, or functional performance.
Ordering and documentation
Choose NAD+ 500 mg when its labeled quantity and documented chemical form align with your laboratory requirements. Before proceeding, review the available batch records and compare the stated specifications with your research or analytical method.
Pure Lab Peptides Supply presents this product as research material, not as an approved medicine or a recommendation for human or veterinary use.
Research-use notice
This material is intended for legitimate laboratory research and analytical purposes only. It is not intended for human consumption, self-administration, diagnosis, treatment, or prevention of disease. Follow applicable laboratory procedures, safety guidance, and institutional requirements.

















